EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Considerations for Microbiological Control Strategy during Oligonucleotide Drug Substance Manufacturing

Deborah Allen, Rick Arts, Gamze Belin, Mandana Borna, Chris Coffin, Sophie Drinkwater, Peter Jehle, Joyce Johnson, Anja Nuydens, Martin Olbrich, Aura R. Ortiz, Mahir Ozdemir und 6 weitere

Organic Process Research & Development · 19.12.2025 · 29 (12) · 3013-3027

DOI: 10.1021/acs.oprd.5c00317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 29.11.2025. Verfasst von Deborah Allen und 17 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Allen, D., Arts, R., Belin, G., Borna, M., Coffin, C., Drinkwater, S., Jehle, P., Johnson, J., Nuydens, A., Olbrich, M., Ortiz, A. R., Ozdemir, M., Quinn, A., Seyberth, T., Smith, P. D., Tremmel, S., Venkatram, B., & Willis, J. (2025). Considerations for Microbiological Control Strategy during Oligonucleotide Drug Substance Manufacturing. Organic Process Research & Development, 29(12), 3013-3027. https://doi.org/10.1021/acs.oprd.5c00317

Vancouver

Allen D, Arts R, Belin G, Borna M, Coffin C, Drinkwater S, et al. Considerations for Microbiological Control Strategy during Oligonucleotide Drug Substance Manufacturing. Organic Process Research & Development. 2025;29(12):3013-3027. doi:10.1021/acs.oprd.5c00317

BibTeX
@article{Allen2025,
  author = {Allen, Deborah and Arts, Rick and Belin, Gamze and Borna, Mandana and Coffin, Chris and Drinkwater, Sophie and Jehle, Peter and Johnson, Joyce and Nuydens, Anja and Olbrich, Martin and Ortiz, Aura R. and Ozdemir, Mahir and Quinn, Andrew and Seyberth, Tobias and Smith, Peter D. and Tremmel, Sandra and Venkatram, Bharath and Willis, Jonathan},
  title = {Considerations for Microbiological Control Strategy during Oligonucleotide Drug Substance Manufacturing},
  journal = {Organic Process Research & Development},
  year = {2025},
  volume = {29},
  number = {12},
  pages = {3013--3027},
  doi = {10.1021/acs.oprd.5c00317}
}
Kostenlos starten →